November 15, 2013 -- Merck KGaA and Johnson & Johnson each announced they will build new manufacturing facilities in China, signifying that multinationals regard recent problems in the China marketplace as a short-term phenomenon, not a long-term trend. Yesterday, in a similar move, Lilly said it would build a $350 million plant in China to produce insulin cartridges. More details....